Sugal & Damani Share Brokers Limited (SUGALDAM.BO)
INR 88.75
(2.0%)
INR 88.75
(2.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -62.33 Million | -116.27 Million | 70.67 Million | -49.45 Million | 40.52 Million |
| Net Income | 29.95 Million | 15.1 Million | 18.1 Million | -2.27 Million | 25.92 Million |
| Depreciation & Amortization | 284 Thousand | 207.62 Thousand | 184.61 Thousand | 184.08 Thousand | 237.25 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -79.56 Million | -120.75 Million | 63.93 Million | -30.42 Million | 32.58 Million |
| Other non-cash items | 836 Thousand | -10.83 Million | -11.54 Million | -16.93 Million | -18.22 Million |
| Investing Cash Flow | 39.16 Million | 105.45 Million | -135.97 Million | 60.91 Million | -2.34 Million |
| Investments in PPE | -309 Thousand | -755.94 Thousand | -102.63 Thousand | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -23.85 Million | -13.34 Million | -223.06 Million | -3.75 Million | -20 Million |
| Sales/Maturities of investments | 57.46 Million | 114.88 Million | 82.4 Million | 50.81 Million | - |
| Other Investing Activities | 5.86 Million | 4.66 Million | 4.78 Million | 13.85 Million | 17.65 Million |
| Financing Cash Flow | 22.37 Million | 10.4 Million | - | -3.36 Million | -6.65 Million |
| Debt repayment | -28.2 Million | -10.49 Million | - | -86.3 Thousand | -47.32 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -5.83 Million | - | - | -3.27 Million | - |
| Accounts receivables | 76.9 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -163.14 Million | -58.31 Thousand | -35.19 Thousand | 10.84 Thousand | 5214.00 |
| Other working capital | 6.68 Million | -120.7 Million | 63.96 Million | -30.43 Million | 32.57 Million |
| Cash at beginning of period | 894 Thousand | 1.3 Million | 66.61 Million | 58.52 Million | 26.98 Million |
| Cash at end of period | 97 Thousand | 893.88 Thousand | 1.3 Million | 66.61 Million | 58.52 Million |
| Capital Expenditure | -309 Thousand | -755.94 Thousand | -102.63 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -797 Thousand | -414.85 Thousand | -65.3 Million | 8.09 Million | 31.53 Million |
| Free Cash Flow | -62.64 Million | -117.03 Million | 70.57 Million | -49.45 Million | 40.52 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | 29.95 Million | 15.1 Million | 18.1 Million | -2.27 Million | 25.92 Million |
| Depreciation & Amortization | 284 Thousand | 207.62 Thousand | 184.61 Thousand | 184.08 Thousand | 237.25 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -79.56 Million | -120.75 Million | 63.93 Million | -30.42 Million | 32.58 Million |
| Other non-cash items | 836 Thousand | -10.83 Million | -11.54 Million | -16.93 Million | -18.22 Million |
| Investing Cash Flow | 39.16 Million | 105.45 Million | -135.97 Million | 60.91 Million | -2.34 Million |
| Investments in PPE | -309 Thousand | -755.94 Thousand | -102.63 Thousand | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -23.85 Million | -13.34 Million | -223.06 Million | -3.75 Million | -20 Million |
| Sales/Maturities of investments | 57.46 Million | 114.88 Million | 82.4 Million | 50.81 Million | - |
| Other Investing Activities | - | 4.66 Million | 4.78 Million | 13.85 Million | 17.65 Million |
| Financing Cash Flow | 22.37 Million | 10.4 Million | - | -3.36 Million | -6.65 Million |
| Debt repayment | -28.2 Million | -10.49 Million | - | -86.3 Thousand | -47.32 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | - | - | - | -3.27 Million | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -163.14 Million | -58.31 Thousand | -35.19 Thousand | 10.84 Thousand | 5214.00 |
| Other working capital | - | -120.7 Million | 63.96 Million | -30.43 Million | 32.57 Million |
| Cash at beginning of period | 894 Thousand | 1.3 Million | 66.61 Million | 58.52 Million | 26.98 Million |
| Cash at end of period | 97 Thousand | 893.88 Thousand | 1.3 Million | 66.61 Million | 58.52 Million |
| Capital Expenditure | -309 Thousand | -755.94 Thousand | -102.63 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -797 Thousand | -414.85 Thousand | -65.3 Million | 8.09 Million | 31.53 Million |
| Free Cash Flow | -62.64 Million | -117.03 Million | 70.57 Million | -49.45 Million | 40.52 Million |
SHIVAGR
HAR
PAT
3611
PGM
AAREYDRUGS